A Clinical Study With MT-102 in Subjects With Cancer Cachexia
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
A phase II clinical study to evaluate MT-102 administered over a sixteen week period in
subjects with cachexia related to non-small cell lung cancer and colorectal cancer